Transparent peer review to be extended to all of Nature’s research papers
From today, all new submissions to Nature that are published will be accompanied by referees’ reports and author responses — to illuminate the process of producing rigorous science.
From today, every paper submitted to Nature -if published - will be accompanied by peer reviewers comments & authors rebuttal.
We started the trial in 2020; we now want to open up the review process & showcase its role in shaping & improving papers
🧪 #AcademicSky
www.nature.com/articles/d41...
16.06.2025 20:29 — 👍 215 🔁 69 💬 9 📌 11
Congratulations!!!
06.04.2025 15:54 — 👍 0 🔁 0 💬 1 📌 0
#ToolsoftheTrade 🚨
Jordan Lee describes the Tumor Molecular Pathology (TMP) machine learning toolkit that can classify new samples into previously defined #TCGA molecular subtypes
@ohsunews.bsky.social
👀 ⬇️
17.03.2025 15:01 — 👍 2 🔁 1 💬 0 📌 0
#REVIEW🚨
Velculescu & Team review targeted and genome-wide #cfDNA detection approaches and discuss their potential to complement existing screening programs or enhance early cancer detection for those cancers without effective screening methods.
11.03.2025 15:18 — 👍 6 🔁 2 💬 0 📌 0
Review
#ResearchHighlight 🚨
@claballabio.bsky.social from Leanne Li group @crick.ac.uk show that #neuroendocrine #SCLC cells exhibit electrical activity that drives tumour progression. They rely on OXPHOS to meet the high energy demand of these electrophysiological processes. 👀⬇️
13.03.2025 15:55 — 👍 1 🔁 1 💬 1 📌 0
Women’s health
Research into women’s health has suffered from historical neglect and lack of funding.
To mark #InternationalWomensDay tomorrow, the #NatureReviews Collection on women's health has been updated. Click below to read articles on various aspects of women's health, including brand new Reviews from @natrevcardiol.bsky.social and @natrevgastrohep.bsky.social go.nature.com/30kDWG3
07.03.2025 10:09 — 👍 32 🔁 21 💬 0 📌 4
#REVIEW🚨
In this Expert Recommendation, @drholowatyj.bsky.social &Co cover the current state of the field in #AppendicealCancer and propose a conceptual research framework to advance knowledge of this rare cancer to deliver better outcomes for patients.
#RareDiseaseDay @acpmpresearch.bsky.social
📖 ⬇️
28.02.2025 15:16 — 👍 9 🔁 5 💬 0 📌 1
Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer - Nature Reviews Cancer
Triantafyllos Stylianopoulos, Rakesh K. Jain & Co review the utility of continuous models & discrete models in therapy delivery and efficacy in cancer and propose ways to integrate mechanistic and AI-based models to improve patient outcomes.
📖 👇
bit.ly/3X7JGAu
24.02.2025 16:30 — 👍 4 🔁 5 💬 0 📌 0
Chromothripsis in cancer - Nature Reviews Cancer
# REVIEW 🚨
Simovic-Lorenz & Ernst from @dkfz.bsky.social discuss mechanisms of #chromothripsis, its impact on cancer and vulnerabilities of chromothriptic tumours.
📖 ⬇️
14.02.2025 18:17 — 👍 9 🔁 5 💬 0 📌 1
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities - Nature Reviews Cancer
Beyond prostate cancer: Androgen receptor signaling plays a key role in multiple malignancies. Dotto & collegues explore AR’s context-dependent functions in cancer cells & the TME, and highlight AR-targeting cancer trials.
📖 👇
15.02.2025 14:28 — 👍 11 🔁 4 💬 0 📌 1
#REVIEW 🚨
Miriam Merad & Co @sinaiimmuno.bsky.social
outline the molecular basis of #DendriticCell maturation and the mechanisms through which cancer impairs #DC maturation and consider the potential for DC-focused cancer #immunotherapeutics.
📖 ⬇️
12.02.2025 17:23 — 👍 6 🔁 3 💬 0 📌 0
Allies in the epidermis - Nature Reviews Cancer
Immunosuppression disrupts normal skin homeostasis, raising the risk of cancer development. Now, Son et al. find that commensal papillomavirus maintains homeostasis in sun-damaged skin.
#RESEARCHHIGHLIGHT
Immunosuppression disrupts normal skin homeostasis, raising the risk of cancer development. Now, in @cp-cancercell.bsky.social, Son et al. find that commensal papillomavirus maintains homeostasis in sun-damaged skin.
Read the highlight here 👇
https://bit.ly/4jL8W...
06.02.2025 15:56 — 👍 5 🔁 3 💬 0 📌 0
Epigenomic heterogeneity as a source of tumour evolution - Nature Reviews Cancer
Single-cell epigenomic technologies are refining our understanding of cancer evolution.
#REVIEW
Vallot, Lupien and Lasine describe how epigenomic heterogeneity generates dynamic reservoirs of tumour cell states, which can be leveraged in the design of novel therapies.
📖 👉 https://bit.ly/40PCQ...
27.01.2025 15:13 — 👍 14 🔁 8 💬 0 📌 1
Welcoming the newest members of the #NatureReviews family @natrevbiodiv.bsky.social & @natrevcleantech.bsky.social on their launch week!
You can follow them and more Reviews journals (and a few Editors) in this starter pack 🧪
go.bsky.app/KcxvQLp
16.01.2025 16:15 — 👍 29 🔁 11 💬 0 📌 0
Check out our latest Research Highlight by @daniela-senft.bsky.social! 👀👇
14.01.2025 12:48 — 👍 9 🔁 6 💬 0 📌 0
Group leader, Liccardi lab, Institute of biochemistry, University of Cologne.
We are interested in cell death inflammation and immunity.
Scientist | Collaborative Leadership Consultant for STEM Leaders and Organizations at BridgUs Lab
Die DFG ist die größte Forschungsförderorganisation und die Selbstverwaltungsorganisation der Wissenschaft in Deutschland.
www.dfg.de
Impressum: https://www.dfg.de/de/service/kontakt/impressum
Social Media-Netiquette: https://www.dfg.de/de/service/presse
Cancer, somatic mutations, Epithelioid models and cell competition
Editor of Nature Photonics. Based in London.
Senior writer @sciencenews.bsky.social. Biochem Ph.D. Covering health, medicine, bio. Sometimes posting my cats. Signal: megrosen.84
Leading global efforts to improve access to cancer care. Advancing education, research, and innovation in hematology & oncology.
📍 Cancer hospitals in Nepal
🎓 CME & conferences worldwide
📅 Join us: https://binaytara.org
#CancerCare #HealthEquity
We are 1 of only 7 NCI-Designated basic research cancer centers in the nation, driving discovery through collaboration and innovation. Our scientists unite cutting-edge technology and multidisciplinary expertise to transform cancer diagnosis and treatment.
Nature Immunology publishes original research, reviews and commentary of the highest quality and significance in all areas of immunology.
Professor, Medical Oncology @UCSD; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, spatial biology, irAEs, wearables, cancer informatics & AI
Lab head in stem cell and cancer epigenetics at PeterMac, UniMelb 🇦🇺🧬
Scientist, mum, dreamer
She/her. Views are my own
www.eckmaslab.com
Editor of Technology in Cancer Research & Treatment (Impact Factor: 2.7; Q2 in Oncology - Scopus & Scimago rankings).
Stanford, cell cycle, RB, cancer, SCLC, mouse models
International research centre devoted to curing #cancer and other diseases linked to #aging. @cerca.cat center, member of @bist.eu.
www.irbbarcelona.org
The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years.
We study how micro-environmental and epigenetic mechanisms drive cancer cells into dormancy. We seek to control this biology to prevent and treat metastasis. https://einsteinmed.edu/faculty/16974/julio-aguirre-ghiso
Computational Biologist @ La Jolla Institute for Immunology
Immunologist at the Moffitt Cancer Center. We study how T cells behave in tumors and infection, their programs and epigenetic control.
Research Fellow @ NTU Singapore
#ChemicalEngineering #EnvironmentalEngineering #Electrochemistry #SciComm 🇸🇬 🇱🇰
https://linktr.ee/rochellesilva